• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

社区药房 2 型糖尿病筛查方案的评估。DiabNow 研究。

Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study.

机构信息

Academic Centre in Pharmaceutical Care, Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, Spain.

Academic Centre in Pharmaceutical Care, Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, Spain.

出版信息

Diabetes Res Clin Pract. 2015 Jun;108(3):e49-52. doi: 10.1016/j.diabres.2015.03.006. Epub 2015 Mar 13.

DOI:10.1016/j.diabres.2015.03.006
PMID:25819481
Abstract

The aim of this study was to assess the performance and feasibility of a protocol for screening type 2 diabetes in community pharmacy. Performance was primarily assessed by measuring stakeholders' adherence (pharmacists, patients and physicians) to the protocol's components.

摘要

本研究旨在评估社区药房 2 型糖尿病筛查方案的性能和可行性。性能主要通过测量利益相关者（药剂师、患者和医生）对方案组件的依从性来评估。

相似文献

1
Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study.社区药房 2 型糖尿病筛查方案的评估。DiabNow 研究。
Diabetes Res Clin Pract. 2015 Jun;108(3):e49-52. doi: 10.1016/j.diabres.2015.03.006. Epub 2015 Mar 13.
2
Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.挪威社区药房中用于识别未确诊2型糖尿病患者的风险评估和糖化血红蛋白测量——一项可行性研究
PLoS One. 2018 Feb 23;13(2):e0191316. doi: 10.1371/journal.pone.0191316. eCollection 2018.
3
Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.发展中国家基层医疗体系中社区药房的糖尿病和心血管疾病风险筛查模型：一项可行性研究
BMJ Open. 2019 Nov 10;9(11):e031246. doi: 10.1136/bmjopen-2019-031246.
4
Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.药房糖尿病筛查试验：一项实用的整群随机对照试验方案，用于比较澳大利亚社区药房中三种未诊断2型糖尿病的筛查方法。
BMJ Open. 2017 Dec 27;7(12):e017725. doi: 10.1136/bmjopen-2017-017725.
5
Pharmacy characteristics correlating to performance in a community pharmacy network.与社区药房网络表现相关的药房特征。
J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):275-279. doi: 10.1016/j.japh.2018.12.017.
6
When procedures meet practice in community pharmacies: qualitative insights from pharmacists and pharmacy support staff.当社区药房的程序与实践相遇：药剂师和药房支持人员的定性见解。
BMJ Open. 2016 Jun 6;6(6):e010851. doi: 10.1136/bmjopen-2015-010851.
7
Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.泰国将社区药房服务纳入国家医疗保险系统相关的结果、成本及利益相关者观点：一项系统综述
Int J Pharm Pract. 2018 Feb;26(1):16-27. doi: 10.1111/ijpp.12385. Epub 2017 Aug 9.
8
The pharmacy screening project--an evaluation of pharmacy-based screening programmes.药房筛查项目——基于药房的筛查计划评估
S Afr Med J. 1999 Sep;89(9):980-6.
9
Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy.药房糖尿病筛查试验（PDST）：一项全国性整群随机对照试验的结果，该试验比较了社区药房中三种未诊断2型糖尿病（T2DM）的筛查方法。
Diabetes Res Clin Pract. 2023 Mar;197:110566. doi: 10.1016/j.diabres.2023.110566. Epub 2023 Feb 3.
10
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.药房糖尿病护理项目：澳大利亚社区药房糖尿病服务模式评估
Diabet Med. 2007 Jun;24(6):677-83. doi: 10.1111/j.1464-5491.2007.02143.x.

引用本文的文献

1
[Detection of people at risk of having diabetes in the community pharmacy with the Findrisc test 2014-2021].[2014 - 2021年在社区药房使用Findrisc测试检测糖尿病高危人群]
Farm Comunitarios. 2023 Oct 23;16(1):5-17. doi: 10.33620/FC.2173-9218.(2024).03. eCollection 2024 Jan 15.
2
Feasibility of a Type 2 Diabetes Prevention Program at Nationwide Level in General Practice: A Pilot Study in Italy.一般实践中全国性2型糖尿病预防项目的可行性：意大利的一项试点研究
J Clin Med. 2024 Feb 16;13(4):1127. doi: 10.3390/jcm13041127.
3
Evaluation of the Community Pharmacy Comorbidities Screening Service on Patients with Chronic Diseases.
社区药房对慢性病患者共病筛查服务的评估
Patient Prefer Adherence. 2021 Jul 17;15:1611-1619. doi: 10.2147/PPA.S312341. eCollection 2021.
4
Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.在英国国民保健署糖尿病预防计划中进行即时 HbA1c 检测的经验：一项观察性研究。
BMJ Open Diabetes Res Care. 2020 Dec;8(2). doi: 10.1136/bmjdrc-2020-001703.
5
Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil.2型糖尿病高危人群的患病率及社区药房参与全国筛查活动情况：巴西的一项开创性行动。
Diabetol Metab Syndr. 2020 Oct 8;12:89. doi: 10.1186/s13098-020-00593-5. eCollection 2020.
6
Diabetes Screening Through Community Pharmacies in England: A Cost-Effectiveness Study.英格兰社区药房糖尿病筛查：一项成本效益研究。
Pharmacy (Basel). 2019 Mar 22;7(1):30. doi: 10.3390/pharmacy7010030.
7
Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.挪威药房糖化血红蛋白（HbA1c）检测的质量控制：一个适度的开端。
J Diabetes Sci Technol. 2018 Jul;12(4):753-761. doi: 10.1177/1932296818766378. Epub 2018 Apr 5.
8
Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.挪威社区药房中用于识别未确诊2型糖尿病患者的风险评估和糖化血红蛋白测量——一项可行性研究
PLoS One. 2018 Feb 23;13(2):e0191316. doi: 10.1371/journal.pone.0191316. eCollection 2018.